Francisco Rodriguez Jr.’s surprising win against the previously undefeated Galal Jafai is now under scrutiny due to “adverse analytical findings” detected in post-fight drug tests conducted on the night of their match. Rodriguez, who achieved a flyweight division record by landing 575 punches, claimed the interim WBC flyweight title with a controversial decision on June 21.
The Voluntary Anti-Doping Association (VADA) has informed Matchroom, the World Boxing Council, and the British Boxing Committee about these findings. Rodriguez responded on social media with skepticism, questioning the timing and validity of the tests, noting that he had undergone three doping tests just six weeks earlier, including one at his home.
This victory positioned 32-year-old Rodriguez for a future bout against the reigning WBC flyweight champion Kenshiro Terazi, who is set to defend his title against Ricardo Sandoval later this month.
Fan Take: This development is crucial for fight fans as it casts doubt on a major upset in the flyweight division and highlights the ongoing challenges of maintaining fair play in combat sports. The outcome could significantly impact the legitimacy of upcoming title fights and the credibility of anti-doping efforts in boxing.
